Insider track record
OtherAcross 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by BELVIN MARCIA. Officer active across 1 company, notably CytomX Therapeutics, Inc.. Aggregated, 10 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €40k. Activity tracked since 22 March 2023. The latest transaction was disclosed on 18 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations10 total
19,512 shares@ US$0.59926.5% of flowCommon StockSEC:0001610717-25-000082:0
35,000 shares0Common StockSEC:0001610717-25-000020:0
30,000 shares0Common StockSEC:0001610717-25-000019:0
11,250 shares0Common StockSEC:0001610717-24-000435:0
12,795 shares@ US$2.085560.8% of flowCommon StockSEC:0001610717-24-000176:0
26,250 shares0Common StockSEC:0001610717-24-000032:0
4,077 shares@ US$1.380512.7% of flowCommon StockSEC:0001610717-23-000422:0
11,250 shares0Common StockSEC:0001610717-23-000408:0
11,250 shares0Common StockSEC:0001610717-23-000299:0
60,000 shares0Common StockSEC:0001140361-23-014592:0